{"id":"https://openalex.org/W7204245273","doi":"https://doi.org/10.1016/j.aohep.2026.102391","title":"#145 - SURVIVAL AND TREATMENT RESPONSE TO ATEZOLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: A REAL-WORLD ANALYSIS FROM REFERRAL ONCOLOGY CENTERS IN COLOMBIA","display_name":"#145 - SURVIVAL AND TREATMENT RESPONSE TO ATEZOLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: A REAL-WORLD ANALYSIS FROM REFERRAL ONCOLOGY CENTERS IN COLOMBIA","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204245273","doi":"https://doi.org/10.1016/j.aohep.2026.102391"},"language":"en","primary_location":{"id":"doi:10.1016/j.aohep.2026.102391","doi":"https://doi.org/10.1016/j.aohep.2026.102391","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.aohep.2026.102391","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1665268126002115/pdf","source":{"id":"https://openalex.org/S32516778","display_name":"Annals of Hepatology","issn_l":"1665-2681","issn":["1665-2681","2659-5982"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hepatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S1665268126002115/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Cristian Villa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I35961687","display_name":"Universidad de Antioquia","ror":"https://ror.org/03bp5hc83","country_code":"CO","type":"education","lineage":["https://openalex.org/I35961687"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Cristian Villa","raw_affiliation_strings":["Department of Internal Medicine, Universidad De Antioquia, Medell\u00edn, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Universidad De Antioquia, Medell\u00edn, Colombia","institution_ids":["https://openalex.org/I35961687"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021513245","display_name":"Hern\u00e1n Jaramillo","orcid":"https://orcid.org/0000-0002-8436-3305","observed_orcids":["https://orcid.org/0000-0002-8436-3305"]},"institutions":[{"id":"https://openalex.org/I35961687","display_name":"Universidad de Antioquia","ror":"https://ror.org/03bp5hc83","country_code":"CO","type":"education","lineage":["https://openalex.org/I35961687"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Hern\u00e1n Jaramillo","raw_affiliation_strings":["Department of Internal Medicine, Universidad De Antioquia, Medell\u00edn, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Universidad De Antioquia, Medell\u00edn, Colombia","institution_ids":["https://openalex.org/I35961687"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014631237","display_name":"Juan Ignacio Mar\u00edn","orcid":"https://orcid.org/0000-0001-6954-8910","observed_orcids":["https://orcid.org/0000-0001-6954-8910"]},"institutions":[{"id":"https://openalex.org/I4210113212","display_name":"Hospital Pablo Tobon Uribe","ror":"https://ror.org/01vtn3k88","country_code":"CO","type":"healthcare","lineage":["https://openalex.org/I4210113212"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Juan Mar\u00edn","raw_affiliation_strings":["Liver Unit and Liver Transplant Program, Hospital Pablo Tob\u00f3n Uribe, Medell\u00edn, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liver Unit and Liver Transplant Program, Hospital Pablo Tob\u00f3n Uribe, Medell\u00edn, Colombia","institution_ids":["https://openalex.org/I4210113212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5127633872","display_name":"Juan Restrepo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113212","display_name":"Hospital Pablo Tobon Uribe","ror":"https://ror.org/01vtn3k88","country_code":"CO","type":"healthcare","lineage":["https://openalex.org/I4210113212"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Juan Restrepo","raw_affiliation_strings":["Liver Unit and Liver Transplant Program, Hospital Pablo Tob\u00f3n Uribe, Medell\u00edn, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liver Unit and Liver Transplant Program, Hospital Pablo Tob\u00f3n Uribe, Medell\u00edn, Colombia","institution_ids":["https://openalex.org/I4210113212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081055279","display_name":"Eliana Higuita-Hern\u00e1ndez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eliana Higuita","raw_affiliation_strings":["Department of Clinical Oncology, Centro Oncol\u00f3gico de Antioquia, Medell\u00edn, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Centro Oncol\u00f3gico de Antioquia, Medell\u00edn, Colombia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117828924","display_name":"Isabel Durango","orcid":"https://orcid.org/0009-0006-4405-9452","observed_orcids":["https://orcid.org/0009-0006-4405-9452"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isabel Durango","raw_affiliation_strings":["Department of Clinical Oncology, Centro Oncol\u00f3gico de Antioquia, Medell\u00edn, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Centro Oncol\u00f3gico de Antioquia, Medell\u00edn, Colombia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5095409446","display_name":"Maria Saavedra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Saavedra","raw_affiliation_strings":["Department of Clinical Hepatology, Cl\u00ednica Las Am\u00e9ricas Auna, Medell\u00edn, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Hepatology, Cl\u00ednica Las Am\u00e9ricas Auna, Medell\u00edn, Colombia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148210517","display_name":"Sergio Cifuentes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sergio Cifuentes","raw_affiliation_strings":["Department of Clinical Oncology, Cl\u00ednica Las Am\u00e9ricas Auna, Medell\u00edn, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Cl\u00ednica Las Am\u00e9ricas Auna, Medell\u00edn, Colombia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116496917","display_name":"N\u00e9stor Llinas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N\u00e9stor Llin\u00e1s","raw_affiliation_strings":["Department of Clinical Oncology, Fundaci\u00f3n Colombiana de Cancerolog\u00eda Cl\u00ednica Vida, Medell\u00edn, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Fundaci\u00f3n Colombiana de Cancerolog\u00eda Cl\u00ednica Vida, Medell\u00edn, Colombia","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"\u00d3scar Beltr\u00e1n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136773","display_name":"Institute of Cardiology","ror":"https://ror.org/04vs72b15","country_code":"CO","type":"facility","lineage":["https://openalex.org/I4210136773"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"\u00d3scar Beltr\u00e1n","raw_affiliation_strings":["Hepatocellular Carcinoma Clinical Excellence Program, Fundaci\u00f3n Cardioinfantil Lacardio, Bogot\u00e1, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hepatocellular Carcinoma Clinical Excellence Program, Fundaci\u00f3n Cardioinfantil Lacardio, Bogot\u00e1, Colombia","institution_ids":["https://openalex.org/I4210136773"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148228377","display_name":"Camila Torres","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136773","display_name":"Institute of Cardiology","ror":"https://ror.org/04vs72b15","country_code":"CO","type":"facility","lineage":["https://openalex.org/I4210136773"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Camila Torres","raw_affiliation_strings":["Department of Clinical Oncology, Fundaci\u00f3n Cardioinfantil Lacardio, Bogot\u00e1, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Fundaci\u00f3n Cardioinfantil Lacardio, Bogot\u00e1, Colombia","institution_ids":["https://openalex.org/I4210136773"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5122763723","display_name":"Fabian Jaimes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I35961687","display_name":"Universidad de Antioquia","ror":"https://ror.org/03bp5hc83","country_code":"CO","type":"education","lineage":["https://openalex.org/I35961687"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Fabi\u00e1n Jaimes","raw_affiliation_strings":["Department of Internal Medicine, Universidad De Antioquia, Medell\u00edn, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Universidad De Antioquia, Medell\u00edn, Colombia","institution_ids":["https://openalex.org/I35961687"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1500,"currency":"USD","value_usd":1500},"apc_paid":{"value":1500,"currency":"USD","value_usd":1500},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.56519459,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":null,"first_page":"102391","last_page":"102391"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.8579999804496765},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/advanced-hepatocellular-carcinoma","display_name":"advanced hepatocellular carcinoma","score":0.925000011920929},{"id":"https://openalex.org/keywords/first-line-systemic-therapy","display_name":"first-line systemic therapy","score":0.7559999823570251},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9070000052452087},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9919999837875366},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.7570000290870667},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8370000123977661},{"id":"https://openalex.org/keywords/aminotransferase-elevation","display_name":"aminotransferase elevation","score":0.8730000257492065},{"id":"https://openalex.org/keywords/gastrointestinal-bleeding","display_name":"gastrointestinal bleeding","score":0.9959999918937683},{"id":"https://openalex.org/keywords/latin-america","display_name":"Latin America","score":0.48100000619888306},{"id":"https://openalex.org/keywords/colombia","display_name":"Colombia","score":0.6430000066757202},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.6660000085830688}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9725000262260437},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.9376000165939331},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8465999960899353},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6944000124931335},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5824999809265137},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5238999724388123},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.460099995136261},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.4472000002861023},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4300000071525574},{"id":"https://openalex.org/C2775832928","wikidata":"https://www.wikidata.org/wiki/Q407954","display_name":"Expanded access","level":2,"score":0.398499995470047},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3490999937057495},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.3479999899864197},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33250001072883606},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.3260999917984009},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.30730000138282776},{"id":"https://openalex.org/C2777214474","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Cirrhosis","level":2,"score":0.3010999858379364},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30059999227523804},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2773999869823456},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.2720000147819519}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.aohep.2026.102391","doi":"https://doi.org/10.1016/j.aohep.2026.102391","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.aohep.2026.102391","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1665268126002115/pdf","source":{"id":"https://openalex.org/S32516778","display_name":"Annals of Hepatology","issn_l":"1665-2681","issn":["1665-2681","2659-5982"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hepatology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.aohep.2026.102391","doi":"https://doi.org/10.1016/j.aohep.2026.102391","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.aohep.2026.102391","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1665268126002115/pdf","source":{"id":"https://openalex.org/S32516778","display_name":"Annals of Hepatology","issn_l":"1665-2681","issn":["1665-2681","2659-5982"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hepatology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204245273.pdf","grobid_xml":"https://content.openalex.org/works/W7204245273.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392157649","https://openalex.org/W4311291415","https://openalex.org/W4328024698","https://openalex.org/W4388562853","https://openalex.org/W4410814611","https://openalex.org/W4383341840","https://openalex.org/W4221006218","https://openalex.org/W4387426289","https://openalex.org/W3212192415","https://openalex.org/W4416460661"],"abstract_inverted_index":{"Introduction":[0],"and":[1,32,51,68,80,104,122,133,141,149,168,172,209,227],"Objectives":[2],"Atezolizumab":[3],"plus":[4,36,64,223],"bevacizumab":[5,37,65,224],"remains":[6,24],"a":[7],"standard":[8],"first-line":[9],"systemic":[10],"treatment":[11,30,98],"option":[12],"for":[13],"advanced":[14,41,59,220],"hepatocellular":[15],"carcinoma":[16],"(HCC).":[17],"However,":[18],"real-world":[19,236],"data":[20,82],"from":[21,85],"Latin":[22,245],"America":[23],"limited.":[25],"To":[26],"evaluate":[27],"survival":[28,89,92,111],"outcomes,":[29],"response,":[31],"safety":[33,228],"of":[34,131,151,183,196,203,216,241],"atezolizumab":[35,63,222],"in":[38,44,48,74,129,147,181,194,201,234,244],"patients":[39,115,218],"with":[40,58,62,109,219],"HCC":[42,60],"treated":[43,61],"routine":[45],"clinical":[46,247],"practice":[47],"Colombia.":[49,75],"Materials":[50],"Methods":[52],"Retrospective":[53],"cohort":[54,215],"study":[55],"including":[56],"adults":[57],"between":[66],"2021":[67],"2026":[69],"at":[70],"referral":[71],"oncology":[72],"centers":[73],"Demographic,":[76],"clinical,":[77],"laboratory,":[78],"treatment,":[79],"outcome":[81],"were":[83,107,116,124,135,145,170],"collected":[84],"medical":[86],"records.":[87],"Overall":[88],"(OS),":[90],"progression-free":[91],"(PFS),":[93],"time":[94,160],"to":[95,101,231],"progression":[96,187],"(TTP),":[97],"response":[99,178],"according":[100],"RECIST/mRECIST":[102],"criteria,":[103],"adverse":[105],"events":[106,199],"evaluated":[108],"Kaplan-Meier":[110],"analysis.":[112],"Results":[113],"Fifty-six":[114],"included":[117],"(mean":[118],"age":[119],"70.3":[120],"years":[121],"66%":[123,130,155],"male).":[125],"Cirrhosis":[126],"was":[127,161,179,188],"present":[128],"patients,":[132,152,184,204],"81%":[134],"classified":[136],"as":[137],"Child-Pugh":[138],"A.":[139],"Metastases":[140],"portal":[142],"vein":[143],"thrombosis":[144],"identified":[146],"28.6%":[148],"26.8%":[150],"respectively.":[153,175],"With":[154],"mortality":[156],"rate,":[157],"median":[158],"OS":[159],"17":[162],"months":[163],"(Figure),":[164],"while":[165],"mean":[166],"PFS":[167],"TTP":[169],"10.3":[171],"9.9":[173],"months,":[174],"Partial":[176],"radiological":[177,186],"observed":[180,233],"8.9%":[182],"whereas":[185],"the":[189,239],"most":[190,205],"frequent":[191],"outcome,":[192],"occurring":[193],"61.5%":[195],"cases.":[197],"Adverse":[198],"occurred":[200],"64.2%":[202],"commonly":[206],"aminotransferase":[207],"elevation":[208],"gastrointestinal":[210],"bleeding.":[211],"Conclusions":[212],"In":[213],"this":[214],"Colombian":[217],"HCC,":[221],"demonstrated":[225],"effectiveness":[226],"outcomes":[229],"comparable":[230],"those":[232],"international":[235],"studies,":[237],"supporting":[238],"reproducibility":[240],"these":[242],"findings":[243],"American":[246],"practice.":[248]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2026-08-27T00:00:00"}